Wherley Eric M, Gross Daniel J, Nguyen Dao M
Section of Thoracic Surgery, Division of Cardiothoracic Surgery, The DeWitt Daughtry Department of Surgery, University of Miami, Miami, FL, USA.
J Thorac Dis. 2023 Sep 28;15(9):5248-5255. doi: 10.21037/jtd-22-1391. Epub 2023 Aug 4.
The management of large mediastinal tumors requires a complex multidisciplinary approach, particularly in the perioperative setting due to increased risk of hemodynamic compromise. The utilization of extracorporeal membrane oxygenation (ECMO) provides a useful adjunct in the surgical management for biopsy and resection of these mediastinal masses. The objective of this article is to review indications and implementation of ECMO in the surgical management of mediastinal disease.
A literature review of the PubMed database was completed evaluating articles discussing 'extracorporeal circulation', 'cardiopulmonary bypass', 'anesthesia', 'mediastinal disease', and 'mediastinal cancer'. These articles were evaluated for contribution to the discussion of indications and implementation of ECMO in the management of these patients.
Large mediastinal tumors place patients at risk of hemodynamic collapse on induction of anesthesia due to compression of vascular structures, tracheobronchial tree and creation of V/Q mismatch. Patients may be stratified regarding their risk of perioperative complications by evaluation of postural symptoms, cross sectional imaging findings and pulmonary function tests. Those patients at elevated perioperative risk may benefit from the utilization of ECMO, most commonly veno-arterial (V-A) ECMO. Guidewires or ECMO cannulas may be placed under local anesthesia prior to induction. Those patients with hemodynamic compromise may receive mechanical circulatory support to allow completion of the operation.
The use of a multidisciplinary team consisting of surgeons, anesthesiologists, perfusionists and OR team is critical to the success in the use of ECMO in the resection of mediastinal masses. With diligent preparation, these high-risk patients may be optimally managed at the time of resection.
大型纵隔肿瘤的治疗需要复杂的多学科方法,尤其是在围手术期,因为血流动力学不稳定的风险增加。体外膜肺氧合(ECMO)的应用为这些纵隔肿物的活检和切除手术管理提供了有用的辅助手段。本文的目的是综述ECMO在纵隔疾病手术管理中的适应证及应用。
完成了对PubMed数据库的文献综述,评估讨论“体外循环”“心肺转流”“麻醉”“纵隔疾病”和“纵隔癌”的文章。评估这些文章对ECMO在这些患者管理中的适应证及应用讨论的贡献。
大型纵隔肿瘤因血管结构受压、气管支气管树受压以及通气/血流不匹配,使患者在麻醉诱导时面临血流动力学崩溃的风险。可通过评估体位症状、横断面影像学检查结果和肺功能测试,对患者围手术期并发症的风险进行分层。那些围手术期风险较高的患者可能受益于ECMO的应用,最常见的是静脉-动脉(V-A)ECMO。在诱导麻醉前,可在局部麻醉下放置导丝或ECMO插管。那些有血流动力学不稳定的患者可接受机械循环支持以完成手术。
由外科医生、麻醉医生、灌注师和手术室团队组成的多学科团队对于成功使用ECMO切除纵隔肿物至关重要。通过精心准备,这些高危患者在切除时可得到最佳管理。